Industry Trend | CDE Publicly Solicits Opinions on "Guideline for Pharmaceutical Research and Evaluation of Human-Derived Stem Cell Products (Draft for Solicitation of Opinions)"

On August 17, the Center for Drug Evaluation of the National Medical Products Administration issued a notice to solicit public opinions on the "Guideline for Pharmaceutical Research and Evaluation of Human-Derived Stem Cell Products (Draft for Solicitation of Opinions)".

Cutting-Edge Research | 3D Microcarrier as a Delivery Tool to Assist Gene-Modified Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes

Type 2 diabetes (T2DM) is one of the most serious chronic diseases that threaten human life and health. The main clinical manifestations are insulin resistance and depletion of pancreatic islet functions. Traditional T2DM drugs are difficult to restore blood glucose back to normal in some patients, and may cause various adverse reactions such as hypoglycemia, diarrhea, nausea, and vomiting.

AHM 细胞微球组装与3D打印结合的新策略

大尺度复杂组织的体外构建存在着包括高活性的细胞扩增，大尺度结构的快速、精确制备，以及合适的细胞微环境等挑战。清华大学医学院的杜亚楠课题组近期在Advanced Healthcare Materials期刊上发表了“TGase‐Enhanced Microtissue Assembly in 3D‐Printed‐Template‐Scaffold (3D‐MAPS) for Large Tissu

祝贺华龛生物原研文章3D干细胞大规模制备工艺荣登《Tissue Engineering》期刊封面！

人源间充质干细胞（hMSCs）在再生医学中具有广泛的应用，但是如何在体外实现规模化扩增生产已成为限制其进行临床转化的一大阻碍，华龛生物自主研发的3D FloTrix™ 自动化扩增工艺技术为此提供了一套完美的解决方案。